A new study finds people addicted to opioids who are treated with the newly approved implanted form of buprenorphine are more likely to maintain abstinence after six months, compared with those taking the pill form of the treatment.
Health insurance companies, facing an increase in claims for substance abuse treatment, are pushing for changes such as emphasizing medication-assisted treatment over abstinence, according to the Hartford Courant.
Doctors say they are finding it challenging to add the newly approved addiction treatment medicine Probuphine to their practice, WBEZ reports. They say they have to learn how to implant the drug in the upper arm of patients. They must also deal with new requirements.
The head of a Canadian clinic that provides legally prescribed heroin to people addicted to the drug told U.S. senators this week the strategy can reduce the risk of serious illness and premature death, while reducing drug-related crime.
Georgia has put a one-year moratorium on issuing licenses to clinics that use medication-assisted treatment for opioid addiction, NPR reports. Legislators say Georgia put a cap on the number of clinics because it wants to determine why so many opioid treatment programs have opened in the state.
Research suggests 50 percent or more of patients with psychiatric disorders abuse some type of drugs, including alcohol. Yet there are relatively few treatment programs that address addiction and mental health disorders together, according to John Tsuang, MD, Director of the Dual Diagnosis Treatment Program at the Harbor-UCLA Medical Center.
In the 19 states that have not expanded Medicaid under the Affordable Care Act, doctors, public health officials and community leaders are struggling to get care to patients who need addiction treatment, the Los Angeles Times reports.